0000315066-18-002099.txt : 20180731 0000315066-18-002099.hdr.sgml : 20180731 20180731150947 ACCESSION NUMBER: 0000315066-18-002099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180727 FILED AS OF DATE: 20180731 DATE AS OF CHANGE: 20180731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FMR LLC CENTRAL INDEX KEY: 0000315066 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37725 FILM NUMBER: 18980887 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6175706339 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER NAME: FORMER CONFORMED NAME: FMR CORP DATE OF NAME CHANGE: 19920717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ViewRay, Inc. CENTRAL INDEX KEY: 0001597313 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 421777485 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 THERMO FISHER WAY CITY: OAKWOOD VILLAGE STATE: OH ZIP: 44146 BUSINESS PHONE: 440-703-3210 MAIL ADDRESS: STREET 1: 2 THERMO FISHER WAY CITY: OAKWOOD VILLAGE STATE: OH ZIP: 44146 FORMER COMPANY: FORMER CONFORMED NAME: Mirax Corp DATE OF NAME CHANGE: 20140116 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-07-27 0 0001597313 ViewRay, Inc. VRAY 0000315066 FMR LLC 245 SUMMER STREET BOSTON MA 02210 0 0 1 1 See Remark 1 Common Stock 2018-07-27 4 S 0 130559 11.6 D 1568552 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-27 4 S 0 18006 11.56 D 1550546 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 2555 11.47 D 1547991 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 6000 11.45 D 1541991 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 400 11.48 D 1541591 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 7800 11.48 D 1533791 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 1600 11.49 D 1532191 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 1200 11.54 D 1530991 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 600 11.52 D 1530391 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 253 11.36 D 1530138 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 68092 11.36 D 1462046 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 11500 11.39 D 1450546 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 2018-07-30 4 S 0 10000 11.44 D 1440546 I F-Prime Capital Partners Healthcare Fund II LP Common Stock 1620 I FIMM, LLC Table I, Column 5 does not include shares beneficially owned by FMR Co. Inc., FIAM LLC, and Fidelity Institutional Asset Management Trust Company, each an indirect, wholly-owned subsidiary of FMR LLC, as a result of acting as investment advisers to various investment companies registered under the Investment Company Act of 1940 and other funds and accounts. FMR LLC and Abigail P. Johnson have no pecuniary interest in such shares of Common Stock. The general partner of F-Prime Capital Partners Healthcare Fund II LP is F-Prime Capital Partners Healthcare Advisors Fund II LP. F-Prime Capital Partners Healthcare Advisors Fund II LP is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. FIMM, LLC is an indirect, wholly-owned subsidiary of FMR LLC. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.31 to $12.24. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.55 to $11.59. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.37 to $11.50. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.35 to $11.55. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.48 to $11.49. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.37 to $11.55. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.50 to $11.54. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.35 to $11.38. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.35 to $11.39. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $11.44 to $11.45. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Marc R. Bryant, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson 2018-07-31